Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Whilst their primary indication remains glycaemic control, emerging evidence suggests GLP-1 receptor agonists exert effects beyond glucose metabolism
In April 2026, CMS announced it is delaying implementation of the Medicare Part D portion of the BALANCE model for the Calendar Year (CY) 2027
Wegovy Pill Approved in the US as First Oral GLP-1 for Weight Management. Novo Nordisk , 22 Dec
This test maps 14 pathways and 150+ genetic insights using key variants like GLP1R rs6923761 and FTO rs9939609, revealing whether you're more responsive to GLP-1 therapy alone or might benefit from dual-compound approaches like GLP-Squared
US$ 27.09
US$ 28.18
US$ 25.53
US$ 27.45
